chr18-54224241-C-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_003927.5(MBD2):​c.319G>A​(p.Asp107Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000501 in 997,120 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.000021 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000023 ( 0 hom. )

Consequence

MBD2
NM_003927.5 missense

Scores

2
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0540
Variant links:
Genes affected
MBD2 (HGNC:6917): (methyl-CpG binding domain protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. The protein encoded by this gene may function as a mediator of the biological consequences of the methylation signal. It is also reported that the this protein functions as a demethylase to activate transcription, as DNA methylation causes gene silencing. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.1478011).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MBD2NM_003927.5 linkuse as main transcriptc.319G>A p.Asp107Asn missense_variant 1/7 ENST00000256429.8 NP_003918.1 Q9UBB5-1
MBD2NM_015832.6 linkuse as main transcriptc.319G>A p.Asp107Asn missense_variant 1/3 NP_056647.1 Q9UBB5-3A0A024R2B8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MBD2ENST00000256429.8 linkuse as main transcriptc.319G>A p.Asp107Asn missense_variant 1/71 NM_003927.5 ENSP00000256429.3 Q9UBB5-1
MBD2ENST00000583046.1 linkuse as main transcriptc.319G>A p.Asp107Asn missense_variant 1/31 ENSP00000464554.1 Q9UBB5-3
MBD2ENST00000398398.6 linkuse as main transcriptc.319G>A p.Asp107Asn missense_variant 1/32 ENSP00000381435.2 X6RBL6

Frequencies

GnomAD3 genomes
AF:
0.0000206
AC:
3
AN:
145552
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000596
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000235
AC:
2
AN:
851466
Hom.:
0
Cov.:
19
AF XY:
0.00000504
AC XY:
2
AN XY:
396610
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000219
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000129
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000206
AC:
3
AN:
145654
Hom.:
0
Cov.:
31
AF XY:
0.0000141
AC XY:
1
AN XY:
70884
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000598
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000189

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 13, 2024The c.319G>A (p.D107N) alteration is located in exon 1 (coding exon 1) of the MBD2 gene. This alteration results from a G to A substitution at nucleotide position 319, causing the aspartic acid (D) at amino acid position 107 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Uncertain
0.035
T
BayesDel_noAF
Benign
-0.19
CADD
Uncertain
24
DANN
Benign
0.94
DEOGEN2
Benign
0.12
T;T;.
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.0040
N
LIST_S2
Benign
0.59
T;T;T
M_CAP
Pathogenic
0.82
D
MetaRNN
Benign
0.15
T;T;T
MetaSVM
Uncertain
0.28
D
MutationAssessor
Benign
0.0
N;.;N
PrimateAI
Pathogenic
0.91
D
PROVEAN
Benign
-0.33
N;N;.
REVEL
Benign
0.21
Sift
Benign
0.031
D;D;.
Sift4G
Benign
0.29
T;T;T
Polyphen
0.30
B;.;B
Vest4
0.13
MutPred
0.31
Gain of MoRF binding (P = 0.0559);Gain of MoRF binding (P = 0.0559);Gain of MoRF binding (P = 0.0559);
MVP
0.68
MPC
1.7
ClinPred
0.17
T
GERP RS
1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.077
gMVP
0.085

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1396640784; hg19: chr18-51750611; API